Lymphatic vessel remodeling and invasion in pancreatic cancer progression

EBioMedicine. 2019 Sep:47:98-113. doi: 10.1016/j.ebiom.2019.08.044. Epub 2019 Sep 5.

Abstract

Background: The lymphatic system is involved in metastasis in pancreatic cancer progression. In cancer staging, lymphatic spread has been used to assess the invasiveness of tumor cells. However, from the endothelium's perspective, the analysis downplays the peri-lesional activities of lymphatic vessels. This unintended bias is largely due to the lack of 3-dimensional (3-D) tissue information to depict the lesion microstructure and vasculature in a global and integrated fashion.

Methods: We targeted the pancreas as the model organ to investigate lymphatic vessel remodeling in cancer lesion progression. Transparent pancreases were prepared by tissue clearing to facilitate deep-tissue, tile-scanning microscopy for 3-D lymphatic network imaging.

Findings: In human pancreatic ductal adenocarcinoma, we identify the close association between the pancreatic intraepithelial neoplasia (PanIN) lesions and the lymphatic network. In mouse models of PanIN (elastase-CreER;LSL-KrasG12D and elastase-CreER;LSL-KrasG12D;p53+/-), the 3-D image data reveal the peri-lesional lymphangiogenesis, endothelial invagination, formation of the bridge/valve-like luminal tubules, vasodilation, and luminal invasion. In the orthotopic mouse model of pancreatic cancer, we identify the localized, graft-induced lymphangiogenesis and the peri- and intra-tumoral lymphatic vessel invasion.

Interpretation: The integrated view of duct lesions and vascular remodeling suggests an active role, rather than a passive target, of lymphatic vessels in the metastasis of pancreatic cancer. Our 3-D image data provide insights into the pancreatic cancer microenvironment and establish the technical and morphological foundation for systematic detection and 3-D analysis of lymphatic vessel invasion. FUND: Taiwan Academia Sinica (AS-107-TP-L15 and AS-105-TP-B15), Ministry of Science and Technology (MOST 106-2321-B-001-048, 106-0210-01-15-02, 106-2321-B-002-034, and 106-2314-B-007-004-MY2), and Taiwan National Health Research Institutes (NHRI EX107-10524EI).

Keywords: Cancer invasion; Kras(G12D) mutation; Lymphangiogenesis; Lymphatic vessel; Lymphovascular invasion; Metastasis; Pancreatic cancer; Pancreatic ductal adenocarcinoma; Pancreatic intraepithelial neoplasia; p53 mutation.

MeSH terms

  • Animals
  • Biomarkers
  • Disease Models, Animal
  • Disease Progression
  • Fluorescent Antibody Technique
  • Heterografts
  • Humans
  • Lymph Nodes / metabolism
  • Lymph Nodes / pathology
  • Lymphatic Vessels / metabolism
  • Lymphatic Vessels / pathology*
  • Mice
  • Neovascularization, Pathologic* / metabolism
  • Pancreatic Neoplasms / metabolism
  • Pancreatic Neoplasms / pathology*
  • Tumor Microenvironment
  • Vascular Remodeling*

Substances

  • Biomarkers